Anemia Diagnosis & Workup: A Systematic Approach | Medical Lecture

Added:

Limitations of the MCV-Centric Algorithmic Approach

While the stepwise approach using Mean Corpuscular Volume (MCV) and Reticulocyte Production Index (RPI) is standard teaching, critics highlight significant limitations. A major drawback is that MCV-based algorithms struggle with mixed-etiology anemias (such as combined iron and B12 deficiency), which often present with a normal MCV and escape early detection. Furthermore, in cases of chronic inflammation or systemic disease, traditional biomarkers like ferritin can act as acute-phase reactants, misleading clinicians who rely strictly on sequential flowcharts. To address these gaps, modern hematology is shifting toward holistic diagnostic models and machine learning systems. These advanced computational approaches analyze complete blood count (CBC) histograms and multiple clinical variables simultaneously, rather than sequentially, to detect complex or multifactorial causes of anemia that traditional diagnostic trees routinely miss.

Basic physiology of erythropoiesis, including the role of erythropoietin (EPO) and bone marrow function in red blood cell production.
Fundamental components of a Complete Blood Count (CBC), specifically Hemoglobin (Hb), Hematocrit (Hct), and Red Blood Cell (RBC) count.
The basic biochemistry of iron metabolism, absorption, transport, and storage in the human body.
General concepts of red blood cell clearance and the physiological mechanisms of extravascular and intravascular hemolysis.
Advanced clinical management and therapeutic interventions for specific anemias, including iron supplementation protocols, B12/folate replacement, and erythropoiesis-stimulating agents.
Interpretation of hemoglobin electrophoresis and genetic testing for diagnosing microcytic hemoglobinopathies such as Thalassemia and Sickle Cell Disease.
Diagnostic workup and management of bone marrow failure syndromes, including aplastic anemia and myelodysplastic syndromes (MDS) via bone marrow aspirate and biopsy.
Differentiating and treating immune-mediated hemolytic anemias using the Direct Antiglobulin (Coombs) Test and understanding the distinction between warm and cold agglutinins.
50K views416likes1:02:44@UofLIMOriginal Release: 2015-03-13

A systematic approach to diagnosing anemia begins with calculating the Reticulocyte Production Index (RPI) to determine whether the anemia results from decreased red blood cell production (RPI < 2%) or increased destruction/loss (RPI > 2%). For decreased production, categorize by MCV: microcytic anemia (MCV < 80) suggests iron deficiency or anemia of chronic disease, while macrocytic anemia (MCV > 100) suggests B12/folate deficiency or alcohol-related causes. For increased destruction, order LDH and haptoglobin; elevated LDH with low haptoglobin indicates hemolytic anemia, requiring DAT testing to differentiate between warm antibody (IgG-mediated) and cold antibody (IgM-mediated) types. Always consider underlying conditions like thalassemia, myelodysplastic syndromes, or paroxysmal nocturnal hemoglobinuria when initial tests are inconclusive.